Antipuesto, Janaya P.

HRN: 22-24-56  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/29/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/29/2022
12/06/2022
IV
145mg
Q12
Neonate Affected By Maternal Uti
Waiting Final Action 
11/29/2022
AMPICILLIN 500MG (VIAL)
11/29/2022
12/06/2022
IV
44mg
Q24
Neonated Affected By Maternal Uti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: